The prevalence of weight loss during (chemo)radiotherapy treatment for lung cancer and associated patient- and treatment-related factors

N Kiss; E Isenring; K Gough; M Krishnasamy

Journal article

The prevalence of weight loss during (chemo)radiotherapy treatment for lung cancer and associated patient- and treatment-related factors

N Kiss, E Isenring, K Gough, M Krishnasamy

Clinical Nutrition | CHURCHILL LIVINGSTONE | Published : 2014

DOI: 10.1016/j.clnu.2013.11.013

Abstract

Background & aims: Thoracic radiotherapy is associated with toxicities that can adversely impact nutritional intake. This study aimed to investigate the prevalence and predictors of ≥5% weight loss and commencement of enteral nutrition in lung cancer patients receiving radiotherapy. Methods: A retrospective study of 96 patients treated with high dose palliative or radical radiotherapy for a primary diagnosis of small cell or non-small cell lung cancer. Weight loss was calculated between the start and up to 90 days from radiotherapy commencement. Associations between ≥5% weight loss and enteral feeding, and demographic and clinical factors (age, gender, nutritional status, total dose of radio..

View full abstract

University of Melbourne Researchers

Meinir Krishnasamy Author

Related Projects (10)

Embedding supportive care as a cornerstone of excellent cancer services

Benefits of home-based rehabilitation in inoperable lung cancer

Understanding nutrition related symptoms, complications and quality of life in patients with gastrointestinal neuroendocrine tumours.

PANSUPPORT: DEVELOPMENT OF AN EXPERIENCE BASED CO-DESIGN, SUPPORTIVE CARE APP WITH AND FOR PEOPLE AFFECTED BY PANCREATIC CANCER

BENEFITS OF HOME-BASED REHABILITATION IN LUNG CANCER

Lung cancer is the third leading cause of death in Australia. People with lung cancer experience a complex mix of symptoms that can provoke ..

THE WOMEN’S WELLNESS AFTER CANCER PROGRAM

Advances in diagnostics, treatment and clinical practice have transformed some cancers from fatal to chronic and sometimes curable diseases...

VCCC - R&E Lead

RANDOMISED PHASE III TRIAL OF ADJUVANT RADIOTHERAPY VERSUS OBSERVATION FOLLOWING BREAST CONSERVING SURGERY AND ENDOCRINE THERAPY IN PATIENTS WITH MOLECULARLY CHARACTERISED LOW-RISK LUMINAL A EARLY BREAST CANCER

Radiotherapy after surgery for early breast cancer decreases recurrence but its benefit varies. Thus, it is important to identify low-risk p..

NATIONAL CENTRE FOR INFECTIONS IN CANCER (NCIC)

This Centre of Research Excellence will translate the best available evidence to improve cancer outcomes through better management of infect..

DEVELOPMENT OF A TAILORED SUPPORTIVE CARE INTERVENTION FOR WOMEN LIVING WITH ADVANCED BREAST CANCER

Grants

Funding Acknowledgements

The study was supported by a PhD scholarship from the Victorian Cancer Agency, Melbourne, Australia. The sponsors had no involvement in the study.

Citation metrics

36Scopus

32Web of Science

42Dimensions

Keywords

Concurrent Chemoradiation Therapy

3211 Oncology and Carcinogenesis

Lung

Radiation Oncology

Nutrition & Dietetics

Life Sciences & Biomedicine

Lung Cancer

Malnutrition

3202 Clinical Sciences

Receiving Radiotherapy

3210 Nutrition and Dietetics

32 Biomedical and Clinical Sciences